DOJ settles its case against Greystar Management, one of the landlords the Antitrust Division has accused of illegally conspiring to increase rents using RealPage software.
Someone should write about how California's ban on employee noncompete agreements has spurred faster progress, greater innovation, and stronger competition in AI, benefitting employees and consumers alike while companies thrive, and what it means for the broader national debate.
Just a reminder that China has placed an exit ban on a seven-year-old US child.
Meanwhile, the Trump admin is softening China policy to get a Xi meeting: sending AI chips to China, canceling Taiwan defense exchanges, and freezing export control and sanction actions.
Prime Therapeutics says we aren’t “special” enough to dispense Cosentyx.
We aren’t “specialty” accredited. Even if we were, we’d most likely still receive the same message from the PBM, effectively steering the patient away.
The only thing “special” about Cosentyx is the price tag of over $7,000 a month.